Curanex Pharmaceuticals Inc — Company profile
Healthcare · Biotechnology · United States
Last price 4.75 USD (At close: Aug 25, 2026) · Market cap 7.45M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Details
| Name | Curanex Pharmaceuticals Inc |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 6 |
| Founded | 2018 |
| Ipo Date | 2025-08-26 |
| Ceo | Jun Liu |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 4.00 |
| Isin | US23126K3041 |
| Cusip | 23126K304 |
| Cik | 2025942 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Jun Liu | Chief Executive Officer, President and Chairman |
| Wanjun Zhang | Chief Financial Officer and Treasurer |
| Dr. Liqin Xie Ph.D. | Chief Operating Officer |
| Dr. Ning Zhang Ph.D. | Chief Technology Officer |
| Dr. Huijuan Zhong Ph.D. | Chief Science Officer and Director |
| Dian Ying Jing | Secretary |
Contact
| Address | 2 Jericho Plaza, Suite 101B, Jericho, New York 11753, United States |
| Phone | 718 673 6078 |
| Website | https://www.curanexpharma.com |